Kinnate lays off 70% of staff, pulls back from programs to save cash after data disappointment

[cafead]

via Kinnate Biopharma is cutting deep. Months after its delayed cancer data disappointed investors, the biotech has revealed it is laying off 70% of its staff and narrowing its pipeline to stretch its cash reserves into the second quarter of 2026.

article source